Tyrosine Kinase Inhibitors Improved Survival of Critically Ill EGFR-Mutant Lung Cancer Patients Undergoing Mechanical Ventilation

Background: Respiratory failure requiring mechanical ventilation is the major reason for lung cancer patients being admitted to the intensive care unit (ICU). Though molecular targeted therapies, especially epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs), have largely impro...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, I-Hsien, Yang, Ching-Yao, Shih, Jin-Yuan, Yu, Chong-Jen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533530/
https://www.ncbi.nlm.nih.gov/pubmed/34680533
http://dx.doi.org/10.3390/biomedicines9101416

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533530/
https://www.ncbi.nlm.nih.gov/pubmed/34680533
http://dx.doi.org/10.3390/biomedicines9101416

Ejemplares similares